Two Sigma Investments, LP Phio Pharmaceuticals Corp. Transaction History

Two Sigma Investments, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.33 - $63.51 $264 - $50,808	-800 Reduced 3.45%	22,398 $8,000
Q3 2022 Nov 14, 2022	SELL	$0.62 - $66.43 $2,848 - $305,245	-4,595 Reduced 16.53%	23,198 $13,000
Q2 2022 Aug 15, 2022	BUY	$0.64 - $2.35 $17,787 - $65,313	27,793 New	27,793 $20,000
Q1 2022 May 16, 2022	SELL	$0.73 - $1.1 $93,968 - $141,596	-128,724 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.99 - $1.99 $85,721 - $172,308	86,587 Added 205.49%	128,724 $129,000
Q3 2021 Nov 15, 2021	BUY	$1.62 - $2.28 $427 - $601	264 Added 0.63%	42,137 $86,000
Q2 2021 Aug 16, 2021	BUY	$1.87 - $2.8 $78,302 - $117,244	41,873 New	41,873 $95,000

Ticker PHIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,658,700
Market Cap $30.2M
Description
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.